Defining the Ideal Time Interval between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer

BACKGROUND: Induction therapy leads to significant improvement in survival for selected patients with Stage IIIA non-small cell lung cancer (NSCLC). The ideal time interval between induction therapy and surgery remains unknown. METHODS: Clinical Stage IIIA NSCLC patients receiving induction therapy...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Thorac Surg
Hlavní autoři: Samson, Pamela, Crabtree, Traves D., Robinson, Cliff G., Morgensztern, Daniel, Broderick, Stephen, Krupnick, A. Sasha, Kreisel, Daniel, Patterson, G. Alexander, Meyers, Bryan, Puri, Varun
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444908/
https://ncbi.nlm.nih.gov/pubmed/28110809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2016.09.053
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky